Multicenter canine lymphoma in a 12-year-old keeshond: Chemotherapy options;Lymphome multicentrique chez un chien keeshond de 12 ans: Choix chimiothérapeutiques

Canadian Veterinary Journal

Volumn 43, Issue 9, 2002, Pages 709-711

  Martineau, Mireille M C ^a  

^a Williamstown Veterinary Services   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINASE; CYCLOPHOSPHAMIDE; DOXORUBICIN; PETHIDINE; PREDNISONE; VINCRISTINE; ANTINEOPLASTIC AGENT;

AGED; ANOREXIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER REGRESSION; CANCER SURVIVAL; CLINICAL FEATURE; CLINICAL PROTOCOL; DOG; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; LETHARGY; LYMPHOMA; MULTIPLE CANCER; NONHUMAN; SURVIVAL TIME; TREATMENT OUTCOME; VOMITING; WEIGHT REDUCTION; ANIMAL; ANIMAL DISEASE; CASE REPORT; DOG DISEASE; PROGNOSIS; REMISSION;

ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DOG DISEASES; DOGS; FEMALE; LYMPHOMA; PROGNOSIS; REMISSION INDUCTION; TREATMENT OUTCOME;

EID: 0036707598     PISSN: 00085286     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Starrak GS, Berry CR, Page RL, Johnson JL, Thrall DE. Correlation between thoracic changes and remission/survival duration in 270 dogs with lymphosarcoma. Vet Radiol Ultrasound 1997;38:411-418.
2. Jeglum KA. Chemoimmunotherapy of canine lymphoma with adjuvant canine monoclonal antibody 231. Vet Clin North Am Small Anim Pract 1996;26:73-85.
3. Nelson RW, Couto CG. Small Animal Internal Medicine, 2nd ed. St. Louis: Mosby, 1998;1123-1133.
4. Rosenthal RC. Lymphoma in dogs: chemotherapy. Vet Clin North Am Small Anim Pract 1996;26:63-71.
5. Valerius KD, Ogilvie GK, Mallinckrodt CH, Getzy DM. Doxorubicin alone or in combination with asparaginase, followed by cyclophosphamide, vincristine, and prednisone for treatment of multicentric lymphoma in dogs: 121 cases (1987-1995). J Am Vet Med Assoc 1997;210:512-516.
6. Khanna C, Lund EM, Redic KA, et al. Randomized controlled trial of doxorubicin versus dactinomycin in a multiagent protocol for treatment of dogs with malignant lymphoma. J Am Vet Med Assoc 1998;213:985-990.
7. Chun R, Garrett LD, Vail DM. Evaluation of a high-dose chemotherapy protocol with no maintenance therapy for dogs with lymphoma. J Vet Intern Med 2000;14:120-124.
8. Piek CJ, Rutteman GR, Teske E. Evaluation of the results of a L-asparaginase-based continuous chemotherapy protocol versus a short doxorubicin-based induction chemotherapy protocol in dogs with malignant lymphoma. Vet Q 1999;21:44-49.
9. Teske E, Van Heerde P, Rutteman GR, Kurzman ID, Moore PF, MacEwen EG. Prognostic factors for treatment of malignant lymphoma in dogs. J Am Vet Med Assoc 1994;204:1722-1728.
10. Zemann BI, Moore AS, Rand WM, et al. A combination chemotherapy protocol (VELCAP-L) for dogs with lymphoma. J Vet Intern Med 1998;12:465-470.